Home » Topics » Regulatory

Regulatory
RSS

CPMP recommends approval of Remicade for ankylosing spondylitis, label expansion

Feb. 26, 2003

Metformin XT NDA accepted for filing by FDA

Feb. 24, 2003

Eligard 30 mg receives FDA approval

Feb. 20, 2003

Approvable letter issued for Zelapar

Feb. 20, 2003

Effexor XR approved for social anxiety disorder

Feb. 14, 2003

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

AstraZeneca completes MRP in E.U. for Symbicort Turbuhaler in COPD

Feb. 12, 2003

FDA approves Zoloft for social anxiety disorder

Feb. 12, 2003

Fludara receives E.U. approval as first-line treatment for B-CLL

Feb. 11, 2003

Positive phase III results obtained for Metformin GR in type 2 diabetes

Feb. 5, 2003

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...